tiprankstipranks
ONO Pharmaceutical Co Ltd (JP:4528)
:4528
Japanese Market
4528
ONO Pharmaceutical Co
RESEARCH TOOLSreports

ONO Pharmaceutical Co (4528) Financial Statements

1 Followers

ONO Pharmaceutical Co Financial Overview

ONO Pharmaceutical Co's market cap is currently ¥1.18T. The company's EPS TTM is ¥; its P/E ratio is 8.84; and it has a dividend yield of 3.63%. ONO Pharmaceutical Co is scheduled to report earnings on ―, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total Revenue¥ 486.87B¥ 502.67B¥ 447.19B¥ 361.36B¥ 309.28B
Gross Profit¥ 335.47B¥ 372.67B¥ 334.28B¥ 264.91B¥ 221.10B
Operating Income¥ 63.38B¥ 163.56B¥ 152.29B¥ 114.91B¥ 92.10B
EBITDA¥ 90.28B¥ 181.70B¥ 169.75B¥ 132.63B¥ 107.92B
Net Income¥ 50.05B¥ 127.98B¥ 112.72B¥ 80.52B¥ 75.42B
Balance Sheet
Cash & Short-Term Investments¥ 210.38B¥ 204.59B¥ 164.29B¥ 116.97B¥ 104.97B
Total Assets¥ 1.06T¥ 913.67B¥ 882.44B¥ 739.20B¥ 745.43B
Total Debt¥ 146.68B¥ 8.86B¥ 9.17B¥ 8.80B¥ 9.05B
Net Debt¥ -57.89B¥ -157.28B¥ -86.97B¥ -60.31B¥ -51.99B
Total Liabilities¥ 275.84B¥ 115.06B¥ 134.62B¥ 77.53B¥ 105.68B
Stockholders' Equity¥ 782.45B¥ 792.96B¥ 741.87B¥ 655.91B¥ 634.13B
Cash Flow
Free Cash Flow¥ 77.03B¥ 106.64B¥ 154.27B¥ 56.33B¥ 66.96B
Operating Cash Flow¥ 82.46B¥ 110.66B¥ 159.61B¥ 61.83B¥ 73.98B
Investing Cash Flow¥ -136.78B¥ 48.08B¥ -100.26B¥ 6.04B¥ -57.59B
Financing Cash Flow¥ 94.30B¥ -89.85B¥ -32.48B¥ -60.24B¥ -24.75B
Currency in JPY

ONO Pharmaceutical Co Earnings and Revenue History

Income Statement >

ONO Pharmaceutical Co Debt to Assets

Balance Sheet >

ONO Pharmaceutical Co Cash Flow

Cash Flow >

ONO Pharmaceutical Co Forecast EPS vs Actual EPS

Earnings >